{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# ***TWITTER SENTIMENT ANALYSIS***\n",
    "\n",
    "###  Sentiment Analysis : \n",
    "It is application of ***Natural Language Processing (NLP)*** that builds systems that try to identify and extract the sentiment content or opinions behind a series of word.\n",
    "\n",
    "Rule-based systems that perform sentiment analysis based on a set of manually crafted rules.\n",
    "\n",
    "We use ***Rule Based Approch*** ,A textBlob library which is in python"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 1: Importing the important Libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: twitter in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (1.18.0)\n",
      "Requirement already satisfied: matplotlib in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (3.1.1)\n",
      "Requirement already satisfied: kiwisolver>=1.0.1 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from matplotlib) (1.1.0)\n",
      "Requirement already satisfied: python-dateutil>=2.1 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from matplotlib) (2.8.0)\n",
      "Requirement already satisfied: cycler>=0.10 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from matplotlib) (0.10.0)\n",
      "Requirement already satisfied: numpy>=1.11 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from matplotlib) (1.17.3)\n",
      "Requirement already satisfied: pyparsing!=2.0.4,!=2.1.2,!=2.1.6,>=2.0.1 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from matplotlib) (2.4.2)\n",
      "Requirement already satisfied: setuptools in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from kiwisolver>=1.0.1->matplotlib) (40.8.0)\n",
      "Requirement already satisfied: six>=1.5 in c:\\users\\jagadish\\appdata\\roaming\\python\\python37\\site-packages (from python-dateutil>=2.1->matplotlib) (1.12.0)\n",
      "Requirement already satisfied: numpy in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (1.17.3)\n",
      "Requirement already satisfied: pandas in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (1.0.3)\n",
      "Requirement already satisfied: python-dateutil>=2.6.1 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from pandas) (2.8.0)\n",
      "Requirement already satisfied: pytz>=2017.2 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from pandas) (2019.3)\n",
      "Requirement already satisfied: numpy>=1.13.3 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from pandas) (1.17.3)\n",
      "Requirement already satisfied: six>=1.5 in c:\\users\\jagadish\\appdata\\roaming\\python\\python37\\site-packages (from python-dateutil>=2.6.1->pandas) (1.12.0)\n",
      "Requirement already satisfied: api in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (0.0.7)\n",
      "Requirement already satisfied: requests in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from api) (2.24.0)\n",
      "Requirement already satisfied: nose in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from api) (1.3.7)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (2020.6.20)\n",
      "Requirement already satisfied: idna<3,>=2.5 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (2.9)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (3.0.4)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (1.25.9)\n",
      "Requirement already satisfied: IPython in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (7.15.0)\n",
      "Requirement already satisfied: pygments in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (2.6.1)\n",
      "Requirement already satisfied: traitlets>=4.2 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (4.3.3)\n",
      "Requirement already satisfied: colorama; sys_platform == \"win32\" in c:\\users\\jagadish\\appdata\\roaming\\python\\python37\\site-packages (from IPython) (0.4.1)\n",
      "Requirement already satisfied: backcall in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (0.2.0)\n",
      "Requirement already satisfied: setuptools>=18.5 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (40.8.0)\n",
      "Requirement already satisfied: jedi>=0.10 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (0.17.1)\n",
      "Requirement already satisfied: decorator in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (4.4.2)\n",
      "Requirement already satisfied: pickleshare in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (0.7.5)\n",
      "Requirement already satisfied: prompt-toolkit!=3.0.0,!=3.0.1,<3.1.0,>=2.0.0 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from IPython) (3.0.5)\n",
      "Requirement already satisfied: ipython-genutils in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from traitlets>=4.2->IPython) (0.2.0)\n",
      "Requirement already satisfied: six in c:\\users\\jagadish\\appdata\\roaming\\python\\python37\\site-packages (from traitlets>=4.2->IPython) (1.12.0)\n",
      "Requirement already satisfied: parso<0.8.0,>=0.7.0 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from jedi>=0.10->IPython) (0.7.0)\n",
      "Requirement already satisfied: wcwidth in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from prompt-toolkit!=3.0.0,!=3.0.1,<3.1.0,>=2.0.0->IPython) (0.2.4)\n",
      "Requirement already satisfied: api in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (0.0.7)\n",
      "Requirement already satisfied: nose in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from api) (1.3.7)\n",
      "Requirement already satisfied: requests in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from api) (2.24.0)\n",
      "Requirement already satisfied: idna<3,>=2.5 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (2.9)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (3.0.4)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (2020.6.20)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in c:\\users\\jagadish\\appdata\\local\\programs\\python\\python37-32\\lib\\site-packages (from requests->api) (1.25.9)\n"
     ]
    }
   ],
   "source": [
    " pip install twitter --user \n",
    " pip install matplotlib --user \n",
    " pip install numpy --user \n",
    " pip install pandas --user\n",
    " pip install api --user\n",
    " pip install IPython --user\n",
    "import sys\n",
    "{sys.executable} -m pip install api\n",
    "\n",
    "import twitter\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "%matplotlib inline\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "- ***Importing necessary library*** \n",
    "\n",
    "1.**Twitter** is for collecting data from twitter.\n",
    "\n",
    "2.**Numpy** is for do scientific calculation.\n",
    "\n",
    "3.**Matplotlib** is for visualising the data.\n",
    "\n",
    "3.**nltk** is natural language toolkit which contains various function and datasets.\n",
    "\n",
    " "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 2: Authenticating our python script"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "api =twitter.Api(consumer_key = \"6wIbKc1r1gxBip6iIHFONAPmC\",\n",
    "                 consumer_secret = \"tCVvZ73O3uoev0CDeWVTC81rlEXNZXqwwormg0y9uSFCFZfg1f\",\n",
    "                 access_token_key = \"816662703582416896-tsI6gqNPYjHPWG4HLbBzjb9hy5EaxVr\",\n",
    "                 access_token_secret = \"OS4LCkXQa0lfK3b1d7c8InhZuUBeCwBYs4FnOFvxXcs8f\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "API Owner Details\n",
      " \n",
      "{\"created_at\": \"Wed Jan 04 15:08:56 +0000 2017\", \"default_profile\": true, \"followers_count\": 7, \"friends_count\": 9, \"id\": 816662703582416896, \"id_str\": \"816662703582416896\", \"location\": \"Vishakhapatnam, India\", \"name\": \"Jagadish Lakhini\", \"profile_background_color\": \"F5F8FA\", \"profile_banner_url\": \"https://pbs.twimg.com/profile_banners/816662703582416896/1520264593\", \"profile_image_url\": \"http://pbs.twimg.com/profile_images/970685673916260352/7ijE5nZ9_normal.jpg\", \"profile_image_url_https\": \"https://pbs.twimg.com/profile_images/970685673916260352/7ijE5nZ9_normal.jpg\", \"profile_link_color\": \"1DA1F2\", \"profile_sidebar_border_color\": \"C0DEED\", \"profile_sidebar_fill_color\": \"DDEEF6\", \"profile_text_color\": \"333333\", \"profile_use_background_image\": true, \"screen_name\": \"jagadish312_\"}\n"
     ]
    }
   ],
   "source": [
    "print(\"API Owner Details\")\n",
    "print(\" \")\n",
    "print(api.VerifyCredentials())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 3: Extracting trending hashtags"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Trending\n",
      " \n",
      "['#RIPTiktok', '#SocialMediaDay', '#BanEVM', '#tuesdayvibes', '#SwineFlu', 'Joonie', 'Paytm', 'NATO', 'DigitalAtmanirbhar WithRoposo', 'RoposoAaya TikTokGaya', 'श्री भूपेंद्र यादव', 'श्री हनुमान', 'Waghama', 'CamScanner', 'Chinese FDI', '#चीन_का_काल_मोदी', '#Sooryavanshi', '#COVAXIN', '#BazaarFtHimanshiKhurana', '#MausiJi_LaxmibaiKelkar', '#TajHotel', '#हूल_क्रांतिदिन1855', '#StepDownEPS', '#TSHighcourtRespond', '#HBDAllariNaresh', '#नुह_अलवर_खुनी_रोड_फोरलेन_करो', '#PMDoCBIEnquiryForSSR', '#HBDThirumuruganGandhi', '#DadabhaiNaoroji', '#Visakhapatnam', '#HondaCity', '#HBDShiyamJack', '#AamirKhan', '#AsteroidDay', '#SMLive', '#CSCBiharDay', '#HBDGnanavelRaja', '#Ask_BLACKPINK', '#happybirthdayavikagor', '#AsiManshi', '#दादाभाई_नौरोजी', '#unlock2guidelines', '#cscupdiwas']\n"
     ]
    }
   ],
   "source": [
    "locationTrending = api.GetTrendsWoeid('23424848', exclude=None)\n",
    "trending =[]\n",
    "[trending.append(trend.name) for trend in locationTrending]\n",
    "print(\"Trending\")\n",
    "print(\" \")\n",
    "print(trending)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 4: Extracting the tweets from twitter for a specific hashtag\n",
    "\n",
    "In the **createTestData** is a function which take input from user and collect the tweets from twitter and store in variable name ***data***."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Enter the term u want to search#COVAXIN\n",
      "We extract 100 for #COVAXIN\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[{'text': \"India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed b… https://t.co/dazz7CqpsD\"},\n",
       " {'text': '#BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 |… https://t.co/HmP7KFPFQY'},\n",
       " {'text': 'Welcome news: Human trials to begin immediately for India’s 1st COVID-19 Vaccine - #COVAXIN™ developed by… https://t.co/9uYWtcyvV6'},\n",
       " {'text': 'RT @sandhyafernez: #Update \\n\\nIndia’s first #Covid_19 vaccine candidate #COVAXIN developed by @BharatBiotech gets DCGI approval; human trial…'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'Hopefully #COVAXIN is not the same!\\n#Corona #Covid_19'},\n",
       " {'text': 'RT @polimernews: இந்தியாவின் முதல் கொரோனா தடுப்பு மருந்து..  மனிதர்களுக்கு பரிசோதிக்க அனுமதி..! #India | #CoronaVaccine | #COVAXIN | #Covid…'},\n",
       " {'text': 'A potential COVID-19 vaccine, the first to be developed in India by Hyderabad-based Bharat Biotech has been given D… https://t.co/fHC6M5mkSV'},\n",
       " {'text': 'RT @Fukkard: Hammaya😊 Oka Good News\\n#Covaxin #BharatBiotech #coronavirus https://t.co/jK2tMkLjST'},\n",
       " {'text': 'भारत के पहले Covid-19 वैक्सीन कैंडिडेट को मानव परीक्षण के पहले और दूसरे चरण की मंजूरी मिल गई है....\\n\\n#Covid-19… https://t.co/yMjIXcyMUh'},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @TirupurTalks: இந்தியாவின் முதல் கோவிட்-19 தடுப்பூசியான #COVAXIN ஜூலை மாதம் முதல் மனிதர்களுக்கு பரிசோதித்து பார்க்கப்படவுள்ளது.\\n\\n#Tirupu…'},\n",
       " {'text': \"RT @ZeeNewsEnglish: India's first COVID-19 vaccine COVAXIN gets nod for human trials\\n\\n#Coronavirus #CoronavirusIndia #COVID19 #COVAXIN\\n\\nhtt…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"DGCI confirmed that India's first Covid19 vaccine named #COVAXIN gets ready to I,II Phases for human trials. trials… https://t.co/WvWW6LalU5\"},\n",
       " {'text': 'RT @Aamitabh2: देश की पहली #COVID19 वैक्\\u200dसीन #COVAXIN को मानवीय परीक्षण की मंज़ूरी----'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @Aamitabh2: देश की पहली #COVID19 वैक्\\u200dसीन #COVAXIN को मानवीय परीक्षण की मंज़ूरी----'},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': 'RT @Aamitabh2: देश की पहली #COVID19 वैक्\\u200dसीन #COVAXIN को मानवीय परीक्षण की मंज़ूरी----'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @VikCOVID19: #COVAXIN: இந்தியாவின் முதல் கொரோனா தடுப்பூசி! -மனிதச் சோதனைக்கு ஒப்புதல் #FightCOVID19 #Vaccine https://t.co/ASzUkcPECs'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @polimernews: இந்தியாவின் முதல் கொரோனா தடுப்பு மருந்து..  மனிதர்களுக்கு பரிசோதிக்க அனுமதி..! #India | #CoronaVaccine | #COVAXIN | #Covid…'},\n",
       " {'text': 'RT @OpIndia_com: Bharat Biotech’s potential COVID-19 vaccine #COVAXIN enters clinical trials after DGCI approval\\nhttps://t.co/hMclOcDgxP'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"#BharatBiotech company has made a lot of vaccines earlier also. And that's the vaccine we're all using. We are conf… https://t.co/hm16CFAiXq\"},\n",
       " {'text': \"RT @dna: Bharat Biotech's indigenous #COVID19 vaccine #COVAXIN gets approval for phase I &amp; II human clinical trials\\n\\nhttps://t.co/6bI1IUQlGY\"},\n",
       " {'text': \"India's first #COVID19 vaccine  #COVAXIN, gets approval for human trials; it has been jointly developed by… https://t.co/L9WvaZYoBq\"},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @umasudhir: Welcome news: Human trials to begin immediately for India’s 1st COVID-19 Vaccine - #COVAXIN™ developed by @BharatBiotech alo…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @airnewsalerts: Drug Controller General of India gives approval for human clinical trials of #COVAXIN, the 1st potential #Covid_19 Vacci…'},\n",
       " {'text': 'RT @BiovoiceNews: BIO-BREAKING: Raising big hopes, #COVAXIN, India’s first #vaccine candidate against #COVID19, developed by @BharatBiotech…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, is set for human trials\\n\\nDETAILS: https://t.co/sMtiDFZupx https://t.co/…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, is set for human trials\\n\\nDETAILS: https://t.co/sMtiDFZupx https://t.co/…\"},\n",
       " {'text': 'RT @Fukkard: Hammaya😊 Oka Good News\\n#Covaxin #BharatBiotech #coronavirus https://t.co/jK2tMkLjST'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': 'RT @pooja_yadav991: Happy news .. \\nEvery test should be successful and may this medicine will come in the market soon.\\n#COVAXIN https://t.c…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"RT @baraju_SuperHit: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by @BharatBiotech successfully enters human trials.\\n\\n@ICM…\"},\n",
       " {'text': 'RT @VikCOVID19: #COVAXIN: இந்தியாவின் முதல் கொரோனா தடுப்பூசி! -மனிதச் சோதனைக்கு ஒப்புதல் #FightCOVID19 #Vaccine https://t.co/ASzUkcPECs'},\n",
       " {'text': 'RT @XpressHyderabad: What is the new vaccine candidate from #Hyderabad - COVAXIN all about? Watch this video to know more\\n\\n#India #COVAXIN…'},\n",
       " {'text': 'RT @VikCOVID19: #COVAXIN: இந்தியாவின் முதல் கொரோனா தடுப்பூசி! -மனிதச் சோதனைக்கு ஒப்புதல் #FightCOVID19 #Vaccine https://t.co/ASzUkcPECs'},\n",
       " {'text': 'இந்தியாவின் முதல் கோவிட்-19 தடுப்பூசியான #COVAXIN ஜூலை மாதம் முதல் மனிதர்களுக்கு பரிசோதித்து பார்க்கப்படவுள்ளது.… https://t.co/6h7wRWuR69'},\n",
       " {'text': \"After completing animal testing , Drug Controller has approved clinical human trails for #India's first #COVID19 va… https://t.co/0fzzRgKvck\"},\n",
       " {'text': 'RT @VikCOVID19: #COVAXIN: இந்தியாவின் முதல் கொரோனா தடுப்பூசி! -மனிதச் சோதனைக்கு ஒப்புதல் #FightCOVID19 #Vaccine https://t.co/ASzUkcPECs'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @polimernews: இந்தியாவின் முதல் கொரோனா தடுப்பு மருந்து..  மனிதர்களுக்கு பரிசோதிக்க அனுமதி..! #India | #CoronaVaccine | #COVAXIN | #Covid…'},\n",
       " {'text': 'RT @Aamitabh2: देश की पहली #COVID19 वैक्\\u200dसीन #COVAXIN को मानवीय परीक्षण की मंज़ूरी----'},\n",
       " {'text': 'RT @AmitPandey__: #आत्मनिर्भरभारत\\n\\nFrom #Hydroxychloroquine to #dexamethasone to #COVAXIN\\n\\nIndia is the real fighter against COVID-19.....…'},\n",
       " {'text': \"RT @_real_donald_: India's first vaccine #COVAXIN get approval for human trails, All the Chinese apps are banned. Cheer up guys happiness i…\"},\n",
       " {'text': 'RT @AmitPandey__: #आत्मनिर्भरभारत\\n\\nFrom #Hydroxychloroquine to #dexamethasone to #COVAXIN\\n\\nIndia is the real fighter against COVID-19.....…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': '#COVAXIN: இந்தியாவின் முதல் கொரோனா தடுப்பூசி! -மனிதச் சோதனைக்கு ஒப்புதல் #FightCOVID19 #Vaccine https://t.co/ASzUkcPECs'},\n",
       " {'text': \"RT @dna: Bharat Biotech's indigenous #COVID19 vaccine #COVAXIN gets approval for phase I &amp; II human clinical trials\\n\\nhttps://t.co/6bI1IUQlGY\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @zeerajasthan_: भारत की वैक्सीन निर्माता भारत बायोटेक ने दावा किया है कि उसने सफलतापूर्वक कोरोना वायरस की वैक्सीन #COVAXIN बना ली है। कं…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @airnewsalerts: Drug Controller General of India gives approval for human clinical trials of #COVAXIN, the 1st potential #Covid_19 Vacci…'},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'देश की पहली #COVID19 वैक्\\u200dसीन #COVAXIN को मानवीय परीक्षण की मंज़ूरी----'},\n",
       " {'text': 'RT @airnewsalerts: Drug Controller General of India gives approval for human clinical trials of #COVAXIN, the 1st potential #Covid_19 Vacci…'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @airnewsalerts: Drug Controller General of India gives approval for human clinical trials of #COVAXIN, the 1st potential #Covid_19 Vacci…'},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @indiacom: The recently developed coronavirus vaccine named COVAXIN, has got the approval for human trials by the Drug Controller Genera…'},\n",
       " {'text': 'RT @BikramS97264319: Science is just like magic it can deal with anything.... Not like baba ramdev pantanjali coronil #COVAXIN https://t.co…'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': 'RT @Sathish96853272: From Hydroxychloroquine To #COVAXIN ... \\nWe are Handling the Cricis pretty well...\\n\\n#COVAXIN gets nod for Human trials…'},\n",
       " {'text': \"RT @mannkibaat: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by @BharatBiotech  in coordination with @ICMRDELHI and NIV (Pu…\"},\n",
       " {'text': \"RT @Pradeepmaiam: #COVAXIN, India's first #COVID19 vaccine candidate, developed by  Bharat Biotech, has been approved by DGCI for Phase I a…\"},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, is set for human trials\\n\\nDETAILS: https://t.co/sMtiDFZupx https://t.co/…\"},\n",
       " {'text': \"RT @dna: Bharat Biotech's indigenous #COVID19 vaccine #COVAXIN gets approval for phase I &amp; II human clinical trials\\n\\nhttps://t.co/6bI1IUQlGY\"},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': 'RT @news7tamil: #BREAKING | இந்தியாவில் கொரோனாவை தடுக்க முதல் தடுப்பூசிக்கு ஒப்புதல்! \\n\\nhttps://t.co/5wMBD3FLqB | #Covid19 | #CoronaVaccine…'},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': \"RT @DDNewslive: India's first #COVID19 vaccine candidate, #COVAXIN, gets approval for human trials; it has been jointly developed by @ICMRD…\"},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': \"RT @BharatBiotech: COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.\\n\\n @ICMR…\"},\n",
       " {'text': 'RT @bsindia: Bharat Biotech’s Covid vaccine candidate #Covaxin is set to undergo human clinical trials in July. \\n\\n@sohinidastweets reports…'}]"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def createTestData(search):\n",
    "    try:\n",
    "        fetchData = api.GetSearch(search,count=100)\n",
    "        print(\"We extract \"+str(len(fetchData))+ \" for \"+search)\n",
    "        return [{\"text\":status.text} for status in fetchData]\n",
    "        #print(\"In try\")\n",
    "    except:\n",
    "        print(\"Data is not Extracted\")\n",
    "        return None\n",
    "search_string = input(\"Enter the term u want to search\")\n",
    "data =createTestData(search_string)\n",
    "data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 5: Preprocessing the data\n",
    "\n",
    "#### - Data cleaning\n",
    "- The tweets from twitter data may contains *usernames,hashtag,word in other language ,extra whitespace,stopwords(like is,am,you,the...)* ,so we have to remove all of these words.\n",
    "\n",
    "- tweets may contains the simliar words such as (like,likes ).both are same words(***stemming words***)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import nltk \n",
    "from nltk import sent_tokenize\n",
    "from string import punctuation \n",
    "from nltk.tokenize import word_tokenize\n",
    "from nltk.corpus import stopwords\n",
    "ensw=set(stopwords.words('english') + list(punctuation) + ['AT_USER','URL'])\n",
    "df=[]\n",
    "for i in range(len(data)):\n",
    "    df.append(data[i].get(\"text\"))    \n",
    "\n",
    "type(df[0])\n",
    "for i in range(len(df)):    \n",
    "    df[i]=df[i].lower() \n",
    "    df[i]=re.sub('((www\\.[^\\s]+)|(https?://[^\\s]+))', '', df[i])\n",
    "    df[i] = re.sub('@[^\\s]+', '', df[i]) # remove usernames\n",
    "    df[i] = re.sub(r'#([^\\s]+)', r'\\1', df[i]) # remove the # in #hashtag\n",
    "    df[i]= re.sub('[^a-zA-Z]',' ',df[i]) #remove words then English\n",
    "    df[i]= re.sub(r'\\b\\w{1,2}\\b', '', df[i]) # Remove words with 2 or fewer letters\n",
    "    df[i] = re.sub(r'\\s\\s+', ' ', df[i]) # Remove whitespace (including new line characters)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 6:  Analysing the tweets\n",
    "\n",
    "- through BarPlot of most frequent tweets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 704 words in the all tweets\n"
     ]
    }
   ],
   "source": [
    "para=[]\n",
    "for i in range(len(df)):\n",
    "    para+=word_tokenize(df[i])\n",
    "filterTweets=([ i for i in para if i not in ensw])\n",
    "tweets=' '\n",
    "tweets = tweets.join(filterTweets)\n",
    "print('There are',len(tweets),'words in the all tweets')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import Counter\n",
    "wordfreq =Counter(filterTweets)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Figure size 1080x360 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1152x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(15,5))\n",
    "l=[]\n",
    "co=[]\n",
    "for letter, count in wordfreq.most_common(20): \n",
    "    l.append(letter)\n",
    "    co.append(count)\n",
    "x_pos = np.arange(len(l)) \n",
    "plt.figure(figsize=(16, 10))\n",
    "plt.bar(x_pos, co,align='center',color='pink')\n",
    "plt.xticks(x_pos, l, rotation=90) \n",
    "plt.xlabel('words')\n",
    "plt.ylabel('counts')\n",
    "plt.title('20 most common words')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Classification of tweets using TextBlob"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of Positive Tweets  5.0 %\n",
      "Percentage of Negative Tweets  1.0 %\n",
      "Percentage of Neutral Tweets  94.0 %\n"
     ]
    }
   ],
   "source": [
    "from textblob import TextBlob\n",
    "\n",
    "def sentiment(tweet):\n",
    "    analysis = TextBlob(tweet)\n",
    "    if analysis.sentiment.polarity > 0:\n",
    "        return 1\n",
    "    elif analysis.sentiment.polarity == 0:\n",
    "        return 0\n",
    "    else:\n",
    "        return -1\n",
    "pos_count=0\n",
    "neg_count=0\n",
    "neu_count=0\n",
    "for i in df:\n",
    "    if(sentiment(i)>0):\n",
    "        pos_count+=1\n",
    "    elif sentiment(i)==0:\n",
    "        neu_count+=1\n",
    "    else:\n",
    "        neg_count+=1\n",
    "        \n",
    "total = pos_count+neu_count+neg_count\n",
    "pos = (pos_count/total)*100\n",
    "neg = (neg_count/total)*100\n",
    "neu = (neu_count/total)*100\n",
    "\n",
    "print(\"Percentage of Positive Tweets \",pos,\"%\")\n",
    "print(\"Percentage of Negative Tweets \",neg,\"%\")\n",
    "print(\"Percentage of Neutral Tweets \",neu,\"%\")\n",
    "        \n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 12: Visualization of Sentiments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "labels = 'positive tweets','negative tweets', 'neutral tweets'\n",
    "sizes = [pos_count,neg_count,neu_count]\n",
    "colors = ['green', 'red','pink']\n",
    "# Plot\n",
    "plt.pie(sizes, labels=labels, colors=colors,autopct='%1.1f%%', shadow=True, startangle=140)\n",
    "\n",
    "plt.axis('equal')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
